147 related articles for article (PubMed ID: 37910672)
1. Identification of epithelial-mesenchymal transition-related biomarkers in lung adenocarcinoma using bioinformatics and lab experiments.
Cheng Y; Shen Y; Fang Q; Duan S; Wang Y; Dai X; Chen Y
Aging (Albany NY); 2023 Oct; 15(21):11970-11984. PubMed ID: 37910672
[TBL] [Abstract][Full Text] [Related]
2.
Zhang W; Li T; Hu B; Li H
Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541
[TBL] [Abstract][Full Text] [Related]
3. SPOCK1, as a potential prognostic and therapeutic biomarker for lung adenocarcinoma, is associated with epithelial-mesenchymal transition and immune evasion.
Liu Y; Han T; Wu J; Zhou J; Guo J; Miao R; Xu Z; Xing Y; Bai Y; Hu D
J Transl Med; 2023 Dec; 21(1):909. PubMed ID: 38087364
[TBL] [Abstract][Full Text] [Related]
4. Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
Tang Y; Jiang Y; Qing C; Wang J; Zeng Z
Aging (Albany NY); 2020 Dec; 13(1):794-812. PubMed ID: 33340396
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
6. Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma.
Li F; Song QZ; Zhang YF; Wang XR; Cao LM; Li N; Zhao LX; Zhang SX; Zhuang XF
Front Genet; 2022; 13():1008416. PubMed ID: 36186418
[No Abstract] [Full Text] [Related]
7. A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma.
Cui Y; Wang X; Zhang L; Liu W; Ning J; Gu R; Cui Y; Cai L; Xing Y
Front Oncol; 2022; 12():974614. PubMed ID: 36185284
[TBL] [Abstract][Full Text] [Related]
8. PLEK2 mediates metastasis and invasion via α5-nAChR activation in nicotine-induced lung adenocarcinoma.
Li Q; Li J; Wang J; Wang J; Lu T; Jia Y; Sun H; Ma X
Mol Carcinog; 2024 Feb; 63(2):253-265. PubMed ID: 37921560
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Four-Gene Signature Associated with the Prognosis Prediction of Lung Adenocarcinoma Based on Integrated Bioinformatics Analysis.
Wu Y; Yang L; Zhang L; Zheng X; Xu H; Wang K; Weng X
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205284
[TBL] [Abstract][Full Text] [Related]
10. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
11. An
Han Y; Wong FC; Wang D; Kahlert C
Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
[TBL] [Abstract][Full Text] [Related]
12. The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma.
Luo D; Fang M; Shao L; Wang J; Liang Y; Chen M; Gui X; Yan J; Wang W; Yu L; Fan X; Wu Q
Front Biosci (Landmark Ed); 2023 Oct; 28(10):271. PubMed ID: 37919050
[TBL] [Abstract][Full Text] [Related]
13. A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma.
Jiang H; Xu S; Chen C
BMC Cancer; 2020 Aug; 20(1):782. PubMed ID: 32819300
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
Front Immunol; 2022; 13():950001. PubMed ID: 36091041
[TBL] [Abstract][Full Text] [Related]
15. MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial-mesenchymal transition in lung adenocarcinoma.
Xia X; Ge Y; Ge F; Gu P; Liu Y; Li P; Xu P
J Cancer Res Clin Oncol; 2024 Feb; 150(2):88. PubMed ID: 38341398
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition-related lncRNAs associated with prognosis and immune cell infiltration in lung adenocarcinoma.
Zhang Q; Wu X; Sun Y; Yang L; Wang Z; Yang Y; Zhao X; Zhang X
Am J Transl Res; 2022; 14(10):7308-7323. PubMed ID: 36398231
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Seven-Gene Signature for Predicting the Prognosis of Lung Adenocarcinoma.
Zhang Y; Zhang X; Lv X; Zhang M; Gao X; Liu J; Xu Y; Fang Z; Chen W
Biomed Res Int; 2020; 2020():1836542. PubMed ID: 33195688
[TBL] [Abstract][Full Text] [Related]
18. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
19. Identification of seven-gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi-omics data analysis.
Zhang S; Zeng X; Lin S; Liang M; Huang H
J Clin Lab Anal; 2022 Feb; 36(2):e24190. PubMed ID: 34951053
[TBL] [Abstract][Full Text] [Related]
20. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
